ONCO
ONCO
NASDAQ · Biotechnology

Onconetix Inc

$1.17
-0.05 (-4.10%)
As of Feb 8, 2:35 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 335.8K 347.3K 304.4K
Net Income 43.0K 52.4K 35.7K
EPS
Profit Margin 12.8% 15.1% 11.7%
Rev Growth +0.6% +12.6% -7.7%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 556.4K 513.3K 557.3K
Total Equity 947.6K 993.8K 1.02M
D/E Ratio 0.59 0.52 0.55
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 73.2K 78.8K 66.7K
Free Cash Flow 45.7K 64.8K 36.1K